Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Stanley Pharmaceuticals (Pvt) Ltd,

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000434 60 linked products · source seen 10 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx60product presentations
G29generic molecules
DF7dosage-form groups
TA6therapeutic areas
PKR60current price records
REG45registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage75%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixStanley Pharmaceuticals (Pvt) Ltd,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 11 Aug 2026Pain & musculoskeletal22 · 37%Anti-infectives19 · 32%Vitamins, minerals & nutrition11 · 18%Respiratory & allergy4 · 7%Gastrointestinal & hepatology3 · 5%Reproductive & genitourinary1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioStanley Pharmaceuticals (Pvt) Ltd,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 11 Aug 202660presentationsSuspension24 · 40%Tablet22 · 37%Capsule7 · 12%Syrup4 · 7%Drops1 · 2%Other1 · 2%Other forms1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionStanley Pharmaceuticals (Pvt) Ltd,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 11 Aug 202645comparable productsBelow market median8 · 18%Near market median20 · 44%Above market median17 · 38%Company median price position+2.8%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsStanley Pharmaceuticals (Pvt) Ltd,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/stanley-pharmaceuticals-pvt-ltdGenerated 11 Aug 2026Mediate Pharmaceutical Pvt Ltd12 shared41% overlapStandpharm Pakistan Pvt Ltd12 shared41% overlapBryon Pharmaceuticals (Pvt.) Ltd12 shared41% overlapHizat Pharmaceutical Industry12 shared41% overlapZafa Pharmaceutical Laboratories (P…11 shared38% overlapValor Pharmaceuticals11 shared38% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Pain & musculoskeletal22 products · 37%
Anti-infectives19 products · 32%
Vitamins, minerals & nutrition11 products · 18%
Respiratory & allergy4 products · 7%
Gastrointestinal & hepatology3 products · 5%
Reproductive & genitourinary1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Analgesics / NSAIDs20 products · 33%
Vitamins / minerals / hematinics11 products · 18%
Nitroimidazole anti-infectives10 products · 17%
Antihistamines3 products · 5%
Antiparasitic medicines2 products · 3%
Antifungals2 products · 3%
Proton pump inhibitors2 products · 3%
Muscle relaxant combinations2 products · 3%
Formulation footprint

Dosage forms

Suspension24 products
Tablet22 products
Capsule7 products
Syrup4 products
Drops1 products
Other1 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 PedrolParacetamol 11presentations 120 mg, 120 mg/5 mL, 250 mg/5 mL, 500 mg · Suspension, Tablet, Drops #2 FenbroIbuprofen 7presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg · Suspension, Tablet #3 LoridLoratadine 3presentations 10 mg, 5 mg/5 mL · Tablet, Suspension #4 BendazolAlbendazole 2presentations 200 mg · Suspension, Tablet #5 RiamMetronidazole 2presentations 200 mg/5 mL, 400 mg · Suspension, Tablet #6 RiamMetronidazole (Benzoate) 2presentations 200 mg/5 mL · Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median818% of comparable products
Near market median20within ±5% of median
Above market median1738% of comparable products
Lowest-price equivalents3ties included
Company median price position +2.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Perl DS 40 mgOmeprazole · Capsule · 14s PKR 25.23/capsule-26.0% vs market median Ferfolic 200 mg + 0.1 mgFerrous sulfate + Folic acid · Capsule · 30s PKR 2.13/capsule-17.9% vs market median Pedrol 120 mg/5 mLParacetamol · Suspension · 60ml PKR 0.87/mL-17.1% vs market median Fenbro 200 mg/5 mLIbuprofen · Suspension · 60ml PKR 1.08/mL-13.7% vs market median Fenbro 200 mg/5 mLIbuprofen · Suspension · 90ml PKR 1.08/mL-13.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 12shared generics Standpharm Pakistan Pvt Ltd145 products · 49 generics 12shared generics Bryon Pharmaceuticals (Pvt.) Ltd120 products · 53 generics 12shared generics Hizat Pharmaceutical Industry33 products · 21 generics 12shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.239 products · 98 generics 11shared generics Valor Pharmaceuticals218 products · 97 generics 11shared generics
Regulatory & price activity

Observed database signals

Registration numbers45
Price-history records73
Products with price history8
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date29 Jul 2026
Latest source observation10 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

60 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Abex-C Vit A 25000 IU Capsule 20s 022852 PKR 92.29 PKR 4.61/capsule No comparator
Bendazol Albendazole 200 mg Suspension 10ml 001423 PKR 50.17 PKR 5.02/mL Near median
Bendazol Albendazole 200 mg Tablet 2's 006095 PKR 31.41 PKR 15.71/tablet Near median
Calsid Calcium phosphate + Calcium lactate + Vitamin D 325 mg + 162 mg + 500 IU Tablet 50s 005837 PKR 29.24 PKR 0.58/tablet No comparator
Calsid Tricalcium phosphate + Vitamin D 210 mg + 350 IU/5 mL Oral liquid 120ml 022846 PKR 107.67 PKR 0.90/mL No comparator
Clozim-1 Clotrimazole 500 mg Tablet 1's 005624 PKR 105.25 PKR 105.25/tablet 13% below median
Clozim-6 Clotrimazole 100 mg Tablet 6's 004622 PKR 126.74 PKR 21.12/tablet Near median
F-S Ferrous sulfate 100 mg/5 mL Oral solution 120ml 001418 PKR 42.24 PKR 0.35/mL No comparator
Fenbro Ibuprofen 400 mg Tablet 250s 096195 PKR 876.75 PKR 3.51/tablet Near median
Fenbro Ibuprofen 100 mg/5 mL Suspension 60ml 043342 PKR 67.75 PKR 1.13/mL 19% above median
Fenbro Ibuprofen 200 mg/5 mL Suspension 60ml 076854 PKR 64.79 PKR 1.08/mL 14% below median
Fenbro Ibuprofen 200 mg/5 mL Suspension 90ml 076854 PKR 97.20 PKR 1.08/mL 14% below median
Fenbro Ibuprofen 100 mg/5 mL Suspension 90ml 043342 PKR 101.34 PKR 1.13/mL 19% above median
Fenbro Ibuprofen 100 mg/5 mL Suspension 450ml 043342 PKR 508.12 PKR 1.13/mL 19% above median
Fenbro Ibuprofen 100 mg/5 mL Suspension 120ml 043342 PKR 135.50 PKR 1.13/mL 19% above median
Ferfolic Ferrous sulfate + Folic acid 200 mg + 0.1 mg Capsule 30s 004340 PKR 63.99 PKR 2.13/capsule 18% below median
Fervit Ferrous sulfate + Folic acid + Ascorbic acid + Thiamine + Riboflavin + Pyridoxine + Nicotinamide 2 mg + 2 mg + 1 mg + 0.5 mg + 10 mg + 150 mg + 50 mg Capsule 30s 022851 PKR 121.34 PKR 4.04/capsule No comparator
Fervit Liquid Thiamine (B1) + Riboflavin (B2) + Pyridoxine (B6) + Cyanocobalamin (B12) + Calcium D-pantothenate + Nicotinamide + Ferrous sulfate + Vitamin C 1.5 mg + 1.5 mg + 1.25 mg + 6.25 mcg + 2.5 mg + 7.5 mg + 131 mg + 125 mg/5 mL Syrup 120ml 022860 PKR 69.58 PKR 0.58/mL No comparator
Furamid Furazolidone + Metronidazole 100 mg + 300 mg Tablet 10s 005121 PKR 35.07 PKR 3.51/tablet No comparator
Furamid Metronidazole (Benzoate) 25 mg/5 mL Suspension 60ml 000638 PKR 40.62 PKR 0.68/mL No comparator
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.